Skip to main navigation Skip to search Skip to main content

Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning

  • Jin Komuro
  • , Yuta Tokuoka
  • , Tomohisa Seki
  • , Dai Kusumoto
  • , Hisayuki Hashimoto
  • , Toshiomi Katsuki
  • , Takahiro Nakamura
  • , Yohei Akiba
  • , Thukaa Kuoka
  • , Mai Kimura
  • , Takahiro Yamada
  • , Keiichi Fukuda
  • , Akira Funahashi
  • , Shinsuke Yuasa

Research output: Contribution to journal › Article › peer-review

Abstract

The number of patients with heart failure and related deaths is rapidly increasing worldwide, making it a major problem. Cardiac hypertrophy is a crucial preliminary step in heart failure, but its treatment has not yet been fully successful. In this study, we established a system to evaluate cardiomyocyte hypertrophy using a deep learning-based high-throughput screening system and identified drugs that inhibit it. First, primary cultured cardiomyocytes from neonatal rats were stimulated by both angiotensin II and endothelin-1, and cellular images were captured using a phase-contrast microscope. Subsequently, we used a deep learning model for instance segmentation and established a system to automatically and unbiasedly evaluate the cardiomyocyte size and perimeter. Using this system, we screened 100 FDA-approved drugs library and identified 12 drugs that inhibited cardiomyocyte hypertrophy. We focused on ezetimibe, a cholesterol absorption inhibitor, that inhibited cardiomyocyte hypertrophy in a dose-dependent manner in vitro. Additionally, ezetimibe improved the cardiac dysfunction induced by pressure overload in mice. These results suggest that the deep learning-based system is useful for the evaluation of cardiomyocyte hypertrophy and drug screening, leading to the development of new treatments for heart failure.

Original languageEnglish
Pages (from-to)181-188
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume632
DOIs
Publication statusPublished - 2022 Dec 3

Keywords

  • Cardiac hypertrophy
  • Deep learning
  • Drug screening
  • Ezetimibe
  • Heart failure

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning'. Together they form a unique fingerprint.

Cite this